期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 20, 期 8, 页码 2549-2551出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2010.02.089
关键词
Steroids; Curcumin derivatives; Steroidogenesis; Androgens; 17 beta-HSD3; Leydig cells
资金
- Wenzhou Science Technology [Y20090003, Y20090009]
- Young Talent Funding of Zhejiang Department of Health [2009QN020]
Non-steroidal compounds that inhibit 17 beta-hydroxysteroid dehydrogenase isoform 3 (17 beta-HSD3), an enzyme catalyzing the final step in testosterone biosynthesis in Leydig cells, are under development for male contraceptive or treatment of androgen dependent diseases including prostate cancer. A series of curcumin analogues with more stable chemical structures were compared to curcumin as inhibitors of 17 beta-HSD3 in rat intact Leydig cells as well as rat and human testis microsomes. (C) 2010 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据